Beacon Tx raised $75m in Series C led by Goldman Sachs Alternatives, joined by the RD Fund, Syncona, Forbion, Oxford Science Enterprises, and Advent.
29 December 2025
29 December 2025
Total investments received (USD): 366.25M
Round value (USD): 75M
Company: Beacon Therapeutics
Related deals
Elevara Medicines raised $70m in Series A funding led by Forbion and Sofinnova Partners, joined by insiders Monograph Capital and Weatherden.
Investments
02 October 2025
Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus
Investments
01 October 2025
Belgium
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain